Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder that affects the carriers of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. Common features of FXTAS include progressive intention tremor, gait ataxia, Parkinsonism, and cognitive decline. The neuropathological hallmarks of FXTAS include ubiquitin-positive intranuclear inclusions throughout brain and marked dropout of Purkinje neurons in cerebellum. The long-term goal of this project is to understand the molecular pathogenesis of FXTAS, and develop effective therapeutic interventions for FXTAS. Several lines of evidence, including our findings from both Drosophila and mouse models, support an RNA (fragile X premutation rCGG repeats)-mediated gain-of-function toxicity model for FXTAS, in which rCGG repeat-binding proteins (RBPs) become functionally limited through sequestration by lengthy rCGG repeats. Our previous work has identified two known RNA-binding proteins, Pur ? and hnRNP A2/B1, as RBPs. We showed that both proteins could modulate rCGG-mediated toxicity, supporting the RNA-mediated sequestration model of FXTAS. Using the translating ribosome affinity purification (TRAP) approach, we have also found that the expression of TDP-43 is significantly reduced in young mouse Purkinje neurons expressing rCGG repeats and that TDP-43 levels can modulate rCGG repeat-mediated toxicity in our FXTAS Drosophila model. Also unexpectedly we found that hnRNP A2/B1 can affect epigenetic modulation through interacting with Tet2, a member of Tet family proteins that converts 5- methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). In this proposal, we plan to continue to use both Drosophila and mouse models to further test the hypothesis that FXTAS results from abnormal RNA metabolism that stems from inappropriate association of RBPs with the RNA produced by FMR1 premutation alleles, and to explore the role of 5hmC-mediated epigenetic modulation in FXTAS pathogenesis. Successful completion of these studies should significantly advance our understanding the molecular pathogenesis of FXTAS. Identifications of genes and pathways involved in FXTAS will provide valuable targets for future pharmacological research aimed at developing drugs for therapy.

Public Health Relevance

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder that affects the carriers of premutation alleles (55-200 CGG repeats) of the fragile X mental retardation 1 (FMR1) gene. The long-term goal of this project is to understand the molecular pathogenesis of FXTAS, and develop effective therapeutic interventions for FXTAS. Here we will use both Drosophila and mouse models to test the hypothesis that FXTAS results from abnormal RNA metabolism that stems from inappropriate association of RBPs with the RNA produced by FMR1 premutation alleles.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS051630-09
Application #
8639182
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Riddle, Robert D
Project Start
2005-04-01
Project End
2019-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
9
Fiscal Year
2014
Total Cost
$626,810
Indirect Cost
$124,880
Name
Emory University
Department
Genetics
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Wang, Zhiqin; Tang, Beisha; He, Yuquan et al. (2016) DNA methylation dynamics in neurogenesis. Epigenomics 8:401-14
Qian, Xuyu; Nguyen, Ha Nam; Song, Mingxi M et al. (2016) Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure. Cell 165:1238-54
Weber, Janine; Bao, Han; Hartlmüller, Christoph et al. (2016) Structural basis of nucleic-acid recognition and double-strand unwinding by the essential neuronal protein Pur-alpha. Elife 5:
Zeng, Yaxue; Yao, Bing; Shin, Jaehoon et al. (2016) Lin28A Binds Active Promoters and Recruits Tet1 to Regulate Gene Expression. Mol Cell 61:153-60
Cheng, Ying; Bernstein, Alison; Chen, Dahua et al. (2015) 5-Hydroxymethylcytosine: A new player in brain disorders? Exp Neurol 268:3-9
Xu, Tianlei; Li, Ben; Zhao, Meng et al. (2015) Base-resolution methylation patterns accurately predict transcription factor bindings in vivo. Nucleic Acids Res 43:2757-66
Poidevin, Mickael; Zhang, Feiran; Jin, Peng (2015) Small-molecule screening using Drosophila models of human neurological disorders. Methods Mol Biol 1263:127-38
Wu, Hao; Xu, Tianlei; Feng, Hao et al. (2015) Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates. Nucleic Acids Res 43:e141
Yao, Bing; Jin, Peng (2014) Unlocking epigenetic codes in neurogenesis. Genes Dev 28:1253-71
Galloway, Jocelyn N; Shaw, Chad; Yu, Peng et al. (2014) CGG repeats in RNA modulate expression of TDP-43 in mouse and fly models of fragile X tremor ataxia syndrome. Hum Mol Genet 23:5906-15

Showing the most recent 10 out of 55 publications